The major factors responsible for the growth of the market during the forecast period include an increase in demand for the montelukast intermediate from API (Active Pharmaceutical Ingredient) manufacturers, an increase in presence of generics as well as rising prevalence of asthma, bronchospasm, allergic rhinitis, and urticaria. The montelukast intermediates are used to prevent wheezing, […]
